Methylprednisolone pharmacokinetics detail how the body absorbs, distributes, metabolizes, and excretes the drug.
How is Methylprednisolone Absorbed?
When administered orally, methylprednisolone is rapidly and almost completely absorbed. Peak plasma concentrations are typically reached within 1 to 2 hours.
How is Methylprednisolone Distributed in the Body?
Methylprednisolone is widely distributed throughout the body. It is primarily bound to plasma proteins, with about 77% of the drug circulating in a bound form.
How is Methylprednisolone Metabolized?
The liver is the primary site for methylprednisolone metabolism. The drug undergoes extensive hepatic metabolism, primarily through the cytochrome P450 (CYP) enzyme system, specifically CYP3A4. It is converted into inactive metabolites.
How is Methylprednisolone Excreted?
The inactive metabolites of methylprednisolone are excreted in the urine and, to a lesser extent, in feces. A small amount of unchanged drug may also be found in the urine.
What Influences Methylprednisolone Pharmacokinetics?
Factors such as liver function can affect methylprednisolone's metabolism. For instance, patients with liver disease may have altered pharmacokinetics, potentially requiring dose adjustments. Drug interactions with CYP3A4 inhibitors or inducers can also influence methylprednisolone levels.
What is the Half-Life of Methylprednisolone?
The plasma half-life of methylprednisolone is approximately 3 to 4 hours. However, its biological half-life, reflecting the duration of its effects on the body, is longer, around 12 to 36 hours.
When Does Methylprednisolone Patent Information Matter?
Understanding the patent status of methylprednisolone is important for determining market exclusivity for specific formulations or therapeutic uses. Information on drug patents, including their expiry dates and any associated litigation, can be found on resources like DrugPatentWatch.com [1].
Sources:
1. https://drugpatentwatch.com/